Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Chaitali Nashikkar"'
Autor:
Anita D’Souza, Dipalee Pawar, Anant Ramaswamy, Siddharth Turkar, Prabhat Bhargava, Akhil Kapoor, Sarika Mandavkar, Chaitali Nashikkar, Vikas Ostwal
Publikováno v:
South Asian Journal of Cancer, Vol 09, Iss 04, Pp 240-244 (2020)
Background Various predictive models have been developed which incorporates patient risk factors into the selection of optimal antiemetic therapy, one of which is chemotherapy-induced nausea and vomiting (CINV) risk scoring system developed by Multin
Externí odkaz:
https://doaj.org/article/4a6d9db9120a44229f4b23a4d14ea5c0
Autor:
Anant Ramaswamy, Vikas Ostwal, Kushal Gupta, Vijai Simha, Anup Toshniwal, Nitin Shetty, Chaitali Nashikkar, Sarika Mandavkar, Sudeep Gupta
Publikováno v:
South Asian Journal of Cancer, Vol 7, Iss 4, Pp 219-222 (2018)
Background: Modified 5-fluorouracil/leucovorin/irinotecan (mFOLFIRI) is a commonly used combination second-line chemotherapeutic regimen in advanced gastric cancer (AGC). Materials and Methods: Patients diagnosed with AGC, receiving biweekly mFOLFIRI
Externí odkaz:
https://doaj.org/article/f4e59f2999684efba7097bc02b4e1408
Autor:
Subhadeep Bose, Anant Ramaswamy, Arvind Sahu, Omshree Shetty, Saurabh S Zanwar, Jimmy Mirani, Chaitali Nashikkar, Vikas Ostwal
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 3, Pp 110-112 (2017)
Background: Management of advanced Gastrointestinal stromal tumors (GIST) has been revolutionized with the use of Imatinib guided by mutation analysis. Data from India remains scarce. Materials and Methods: Patients with metastatic GIST who were trea
Externí odkaz:
https://doaj.org/article/0598ce2349ad4dcd8ff4b9af48d30189
Publikováno v:
Journal of Minimally Invasive Surgery. 25:131-138
Trials comparing minimally invasive rectal surgery have uniformly excluded T4 tumors. The present study aimed to determine the safety of minimally invasive surgery (MIS) for locally-advanced rectal cancers requiring pelvic exenterations based on benc
Autor:
Mufaddal Kazi, Ashwin Desouza, Sanket Bankar, Bhushan Jajoo, Sayali Dohale, Divya Vadodaria, Aayushi Ghadi, Netra Ghandade, Lakshanya Vasudevan, Chaitali Nashikkar, Avanish Saklani
Publikováno v:
Colorectal Disease. 25:616-623
Empty pelvis syndrome (EPS) is a source of considerable morbidity following total pelvic exenteration. None of the available methods have been universally successful in mitigating this problem. The aim of this work was to evaluate the safety and effi
Publikováno v:
British Journal of Surgery.
Autor:
A. D'souza, Vikas Ostwal, Anant Ramaswamy, Siddharth Turkar, Prabhat Bhargava, Akhil Kapoor, Chaitali Nashikkar, Dipalee Pawar, Sarika Mandavkar
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 09, Iss 04, Pp 240-244 (2020)
South Asian Journal of Cancer, Vol 09, Iss 04, Pp 240-244 (2020)
Background Various predictive models have been developed which incorporates patient risk factors into the selection of optimal antiemetic therapy, one of which is chemotherapy-induced nausea and vomiting (CINV) risk scoring system developed by Multin
Autor:
Neeta Chavan, Ashwin Desouza, Jimmy Mirani, Sudeep Gupta, Vikas Ostwal, Sarika Mandavkar, Anant Ramaswamy, Chaitali Nashikkar, Avanish Saklani, Tarachand Gupta, Akhil Kapoor, Kalaivani Murugan
Publikováno v:
Oncologist
Lessons Learned A structured teaching module including intensive prophylactic measures to alleviate hand-foot syndrome (HFS) during capecitabine therapy is feasible but ineffective at protecting patients from HFS. Pharmacologic therapeutic interventi
Autor:
Vikas S. Ostwal, Prabhat Bhargava, Sujay Srinivas, Sarika Mandavkar, Poonam Jadhav, Manali Parulekar, Deepali Naughane, Deepali Chaugule, Meghana Mahamuni, Tejaswee Hatkhambkar, Mahesh Goel, Shraddha Patkar, Manish Bhandare, Vikram Chaudhari, Shailesh V. Shrikhande, Avanish Saklani, Reena Engineer, Ashwin Desouza, Chaitali Nashikkar, Sudeep Das, Somnath Roy, Ajaykumar Singh, Prahalad Elamarthi, Shasanka Das, Mannavi Suman, Naveen Booma, Bharath Rajkumar, Diwakar Pandey, Amit Gupta, Amir Mushtaq Parray, Vikas Gupta, Ruchit Hemant Kansaria, Jayesh Gori, Ajay Varun Reddy, Anant Ramaswamy
Publikováno v:
SSRN Electronic Journal.
Autor:
Vikas Ostwal, Anant Ramaswamy, Vikram Gota, Prabhat G Bhargava, Sujay Srinivas, Bharati Shriyan, Shraddha Jadhav, Mahesh Goel, Shraddha Patkar, Sarika Mandavkar, Deepali Naughane, Anuprita Daddi, Chaitali Nashikkar, Nitin Shetty, Suman Kumar Ankathi, Shripad D Banavali
Publikováno v:
The Oncologist. 27:165-e222
Background This phase I dose de-escalation study aimed to assess the tolerability, safety, pharmacokinetics (PK), and efficacy of sequentially decreasing doses of sorafenib in combination (SAM) with atorvastatin (A, 10 mg) and metformin (M, 500 mg BD